학술논문
PND47 Socioeconomic Value of Ocrelizumab in the Treatment of Patients with Relapsing Forms of Multiple Sclerosis
Document Type
Abstract
Author
Source
In Value in Health December 2020 23 Supplement 2:S631-S631
Subject
Language
ISSN
1098-3015